Navigating Treatment Options for Glioblastoma Multiforme

Exploring Bevacizumab as a second-line chemotherapy, radiation therapy effects, and the promise of immunotherapy in tackling glioblastoma, with a focus on TIGIT and innovative treatments being researched at Yale.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app